Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study

被引:48
作者
Cho, Yun Kyung [1 ,2 ]
Kang, Yu Mi [3 ]
Yoo, Jee Hee [1 ]
Lee, Jiwoo [1 ]
Park, Joong-Yeol [1 ]
Lee, Woo Je [1 ]
Kim, Ye-Jee [4 ]
Jung, Chang Hee [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea
[3] Univ Ulsan, Int Healthcare Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2019年 / 97卷
关键词
Obesity; Metabolic syndrome; Cardiovascular disease risk; Cardiovascular mortality; Mortality; DISEASE; ADULTS; OVERWEIGHT; STABILITY; LEVEL;
D O I
10.1016/j.metabol.2019.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: We hypothesized that transitions in metabolic health status and obesity affect the cardiovascular (CV) risk and mortality in population with metabolically healthy obesity (MHO). Methods: This study enrolled 514,866 participants from the Korean National Health Insurance Service National Sample Cohort. Changes in metabolic health status and obesity from the baseline examination in 2009-2010 to the next biannual health examination in 2011-2012 were determined. Study participants were categorized into four groups: (1) metabolically healthy, non-obese (MHNO), defined as BMI < 25 kg/m(2) and no or one metabolic risk factor; (2) metabolically unhealthy, non-obese (MUNO), defined as BMI < 25 kg/m(2) and >= 2 metabolic risk factors; (3) MHO, defined as BMI >= 25 kg/m(2) and no or one metabolic risk factor; and (4) metabolically unhealthy, obese (MUO), defined as BMI >= 25 kg/m(2) and >= 2 metabolic risk factors. The study subjects were followed-up from 2011 to 2015 for cardiovascular events, CV mortality and all-cause mortality. Results: Among the subjects classified as MHO in 2009-2010, 45.6% were classified as MHO in 2011-2012, whereas 11.6%, 6.0%, and 36.8% were classified as MHNO, MUNO, and MUO, respectively. The risk of CV events was higher in baseline MHO group than MHNO group (HR, 1.14; 95% a, 1.05-1.24). However, in baseline MHO group, CV mortality was not increased (HR, 0.85; 95% CI, 0.69-1.06) and all-cause mortality was even lower than that of MHNO group (HR. 0.86; 95% CI, 0.79-0.93). Compared to the stable MHO subjects, the risk of CV events was significantly higher in the subjects who transitioned from MHO to MUO with multivariate-adjusted HRs of 1.24 (95% CI: 1.00-154). When weight loss and progression to metabolic unhealthy phenotype occur simultaneously in the MHO population, the all-cause mortality was increased compared to the stable MHO group (HR, 1.96; 95% CI, 1.45 2.65). Conclusions: Subjects with MHO constitute a heterogeneous group. Our finding supports that evolving to a metabolically unhealthy status and losing weight simultaneously is associated with the adverse outcome in the MHO population. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 33 条
  • [31] Metabolically Healthy but Obese, a Matter of Time? Findings From the Prospective Pizarra Study
    Soriguer, Federico
    Gutierrez-Repiso, Carolina
    Rubio-Martin, Elehazara
    Garcia-Fuentes, Eduardo
    Cruz Almaraz, Maria
    Colomo, Natalia
    Esteva de Antonio, Isabel
    Soledad Ruiz de Adana, Maria
    Javier Chaves, Felipe
    Morcillo, Sonsoles
    Valdes, Sergio
    Rojo-Martinez, Gemma
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (06) : 2318 - 2325
  • [32] Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
    Stefan, Norbert
    Haering, Hans-Ulrich
    Schulze, Matthias B.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (03) : 249 - 258
  • [33] Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
    Stefan, Norbert
    Schick, Fritz
    Haering, Hans-Ulrich
    [J]. CELL METABOLISM, 2017, 26 (02) : 292 - 300